BioWave’s non-opioid pain relief technology now at 80 VA medical centers
Proprietary, Non-Opioid Treatment for Pain Captures 50% of the VA Hospital Market in One Year
Norwalk, Conn. – October 22nd, 2018 – BioWave Corp., a Health Technology company that delivers Smarter Pain Blocking Technology™ today announced that its patented technology is now in use at more than 80 U.S. Department of Veterans Affairs (VA) Medical Centers nationwide. athlete includes 8 of the 19 VA Centers of Innovation (COINs), which lead the charge in specific areas of patient care.
“As the opioid epidemic continues to rage and with new laws around prescription pain medications it is more important than ever that our veterans have access to a non-opioid, non-addictive effective technology like BioWave,” commented Rob Wolter, CEO. “We are encouraged by the willingness and leadership on behalf of VA health professionals to embrace BioWave to help veterans obtain our non-opioid and effective tool to help manage and block chronic or acute pain.”
BioWave’s FDA-cleared, high-frequency neurostimulation technology, described in more detail on its website, delivers soothing therapeutic signals through the skin into deep tissue, blocking pain signals at the source.
“Without BioWave I would have been unable to function in life because of my back. I can’t say enough good things about BioWave or the reps that assisted me in obtaining a BioWaveHOME. It has physically changed my back and is helping me every day to get stronger. If you have chronic pain almost anywhere on your body, please call BioWave and feel the change. And if you are a Veteran with chronic pain get this incredible device.” Jerome Rillera, Cape Coral, FL., Vietnam Veteran.
“As with numerous other patients, we appreciate Jerome sharing his experience with our proprietary pain-blocking technology,” commented Brad Siff, Founder, and President. “Feeling is believing, whether for veterans like Jerome, active military, professional athletes or people from all walks of life. We are so pleased by the partnership we have developed with VA Medical Centers from coast to coast, and we look forward to expanding into all VA healthcare facilities.”
BioWave is available under Federal Supply Schedule contract number V797D-70205.